Einsatz von Stammzellen in der Therapie von Lahmheiten beim Pferd

Summary

Stem cells have been used for the treatment of equine tendon injuries with excellent success for several years. Also for the treatment of joint disease stem cells are regarded as a promising tool. This article focuses on the implementation of stem cell therapy into clinical practice. Besides the scientific background, indications and prospects of success are discussed and practical know-how concerning sample collection and stem cell application is provided.

Key words

stem cell therapy - mesenchymal stem cell - tendon - cartilage - bone marrow - adipose tissue

Literatur

• 1 Burk J, Brehm W. Stammzellentherapie von Sehnenverletzungen – klinische Ergebnisse von 98 Fällen.  Pferdeheilkunde. 2011;  27 (angenommen)
• 2 Caplan A I, Bruder S P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century.  Trends Mol Med. 2001;  7 259-264
• 3 Crovace A, Lacitignola L, Rossi G, Francioso E. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon.  Vet Med Int. 2010;  Epub 2010
• 4 Dahlgren L A. Fat-derived mesenchymal stem cells for equine tendon repair.  Regen Med. 2009;  4 (Suppl. 2) 13
• 5 Del Bue M, Ricco S, Ramoni R, Conti V, Gnudi G, Grolli S. Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo.  Vet Res Commun. 2008;  32 (Suppl. 1) S51-S55
• 6 Delling U, Lindner K, Ribitsch I, Jülke H, Brehm W. Comparison of bone marrow aspiration at the sternum and the tuber coxae in the horse. Helsinki, Finland; Proceedings of the European College of Veterinary Surgeons Annual Scientific Meeting 2010
• 7 Dowling B A, Dart A J, Hodgson D R, Smith R K. Superficial digital flexor tendonitis in the horse.  Equine Vet J. 2000;  32 369-378
• 8 Durgam S S, Stewart A A, Caporali E H, Karlin W M, Stewart M C. Effect of tendon-derived progenitor cells on a collagenase-induced model of tendinitis in horses.  Regen Med. 2009;  4 (Suppl. 2) 27
• 9 Dyson S J. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992–2000).  Equine Vet J. 2004;  36 415-419
• 10 Ferris D J, Frisbie D D, Kisiday J M C V, Hague B A, Major M D, Schneider R K et al. Clinical follow-up of horses treated with bone-marrow derived mesenchymal stem cells for muskuloskeletal lesions. Las Vegas, Nevada; Proceedings of the American Association of Equine Practicioners Conference 2009: 59
• 11 Guest D J, Smith M R, Allen W R. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study.  Equine Vet J. 2008;  40 178-181
• 12 Kasashima Y, Smith R, Goodship A. Optimizing the recovery of mesenchymal progenitor cells from bone marrow.  Regen Med. 2009;  4 (Suppl. 2) 19-20
• 13 Nickel R, Schummer A, Seiferle E. Lehrbuch der Anatomie der Haustiere.. 6. Aufl. Stuttgart: Parey in MVS; 1992
• 14 Pacini S, Spinabella S, Trombi L, Fazzi R, Galimberti S, Dini F et al. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.  Tissue Eng. 2007;  13 2949-2955
• 15 Schnabel L V, Lynch M E, van der Meulen M C, Yeager A E, Kornatowski M A, Nixon A J. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons.  J Orthop Res. 2009;  27 1392-1398
• 16 Smith R K. Mesenchymal stem cell therapy for equine tendinopathy.  Disabil Rehabil. 2008;  30 1752-1758
• 17 Smith R K, Korda M, Blunn G W, Goodship A E. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.  Equine Vet J. 2003;  35 99-102